Hemispherx Biopharma Inc reported raising $25,700 in an initial SEC Form D filing, from an offering of $25,700
Amount Raised
$25,700
Round Type
Pre-Seed
OcalaBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalWho else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as AIM ImmunoTech that raised within 45 days of this round, from Fundz verified event records.
- Aquestive Therapeutics, Inc. raised $9.1M on May 9, 2018.
- EyePoint, Inc. raised $450K (Seed) on April 12, 2018.
- EyePoint, Inc. raised $9.5M on April 12, 2018.
- Praxis Precision Medicines, Inc. raised $19M on March 26, 2018.
- Azora Therapeutics, Inc. (DE) raised $500K on March 13, 2018.
- IRulya Therapeutics Inc. raised $84M on May 31, 2018.
Who to call at AIM ImmunoTech, and when
A new round usually means AIM ImmunoTech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AIM ImmunoTech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AIM ImmunoTech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AIM ImmunoTech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AIM ImmunoTech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AIM ImmunoTech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.